Zobrazit v EDS

Mind it! A mindfulness-based group psychotherapy for substance use disorders in adolescent inpatients

Uloženo v:
Podrobná bibliografie
Název: Mind it! A mindfulness-based group psychotherapy for substance use disorders in adolescent inpatients
Autoři: Legenbauer, Tanja, Baldus, Christiane, Jörke, Carina, Kaffke, Lara, Pepic, Amra, Daubmann, Anne, Zapf, Antonia, Holtmann, Martin, Arnaud, Nicolas, Thomasius, Rainer, the IMAC-Mind Consortium
Zdroj: Eur Child Adolesc Psychiatry
Informace o vydavateli: Springer Science and Business Media LLC, 2024.
Rok vydání: 2024
Témata: Male, Original Paper, Inpatients, Marijuana Abuse, Craving [MeSH], Adolescent [MeSH], Female [MeSH], Adolescents, Marijuana Abuse/therapy [MeSH], Cannabis, Humans [MeSH], Psychotherapy, Group/methods [MeSH], Treatment Outcome [MeSH], Substance use disorders, Mindfulness/methods [MeSH], Mindfulness, Male [MeSH], Germany [MeSH], Young Adult [MeSH], Inpatients/psychology [MeSH], Marijuana Abuse/psychology [MeSH], Substance-Related Disorders/therapy [MeSH], Treatment, Adolescent, Substance-Related Disorders, 05 social sciences, 3. Good health, Young Adult, 03 medical and health sciences, Treatment Outcome, 0302 clinical medicine, Germany, Psychotherapy, Group, Humans, Female, 0501 psychology and cognitive sciences, Craving
Popis: Cannabis use disorder (CUD) is the most frequent reason for psychiatric inpatient substance use disorder (SUD) treatment among 15–19-year-olds in Germany. Despite effective treatment programs, relapse rates remain high. Thus, existing multi-component programs (TAU) need to be enhanced with SUD-specific elements. Mindfulness-based interventions (MBI) seem promising as they can positively influence SUD-related behaviors (e. g. craving). Given limited research in adolescents, this randomized controlled trial investigated the extent to which MBI-based group therapy (Mind it!) as an add-on treatment to TAU led to fewer cannabis use days after 6 months in 84 adolescent inpatients with CUD. Additionally, craving, severity of CUD, and changes in mindfulness were monitored (pre-, post-, and follow-up (FU) assessments). The results revealed a significant reduction in cannabis use days in both groups at 6-month FU (d = − 0.72 and = − 0.75). Although minor additional benefits of Mind it! were evident post-treatment, specifically reduction of craving and SUD severity, by the 6-month mark, TAU exhibited a more substantial decrease in SUD severity (d = 0.78), and reward craving (d = 0.28) compared to Mind it!. Regarding self-regulation skills (mindfulness), Mind it! demonstrated superiority over TAU after 6-month FU (d = 0.27). Therapists judged the MBI as feasible. (Serious) adverse events were unrelated to Mind it!. There was a systematic dropout among Mind it! participants. Primarily, the results emphasize the effectiveness of TAU in reducing cannabis use. MBI also seem feasible for youth, but results remain inconsistent and unstable over time. Importantly, enhanced adherence to reduce dropouts is needed.Trial registration: German Clinical Trials Register, DRKS00014041. Registered on 17 April 2018.
Druh dokumentu: Article
Other literature type
Jazyk: English
ISSN: 1435-165X
1018-8827
DOI: 10.1007/s00787-024-02465-z
Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38748240
https://repository.publisso.de/resource/frl:6499435
Rights: CC BY
Přístupové číslo: edsair.doi.dedup.....6da9adb994da73fec2c289c41097910f
Databáze: OpenAIRE
Popis
Abstrakt:Cannabis use disorder (CUD) is the most frequent reason for psychiatric inpatient substance use disorder (SUD) treatment among 15–19-year-olds in Germany. Despite effective treatment programs, relapse rates remain high. Thus, existing multi-component programs (TAU) need to be enhanced with SUD-specific elements. Mindfulness-based interventions (MBI) seem promising as they can positively influence SUD-related behaviors (e. g. craving). Given limited research in adolescents, this randomized controlled trial investigated the extent to which MBI-based group therapy (Mind it!) as an add-on treatment to TAU led to fewer cannabis use days after 6 months in 84 adolescent inpatients with CUD. Additionally, craving, severity of CUD, and changes in mindfulness were monitored (pre-, post-, and follow-up (FU) assessments). The results revealed a significant reduction in cannabis use days in both groups at 6-month FU (d = − 0.72 and = − 0.75). Although minor additional benefits of Mind it! were evident post-treatment, specifically reduction of craving and SUD severity, by the 6-month mark, TAU exhibited a more substantial decrease in SUD severity (d = 0.78), and reward craving (d = 0.28) compared to Mind it!. Regarding self-regulation skills (mindfulness), Mind it! demonstrated superiority over TAU after 6-month FU (d = 0.27). Therapists judged the MBI as feasible. (Serious) adverse events were unrelated to Mind it!. There was a systematic dropout among Mind it! participants. Primarily, the results emphasize the effectiveness of TAU in reducing cannabis use. MBI also seem feasible for youth, but results remain inconsistent and unstable over time. Importantly, enhanced adherence to reduce dropouts is needed.Trial registration: German Clinical Trials Register, DRKS00014041. Registered on 17 April 2018.
ISSN:1435165X
10188827
DOI:10.1007/s00787-024-02465-z